Equiparin 50.000 IU/100 g gel for horses
  • Heparin sodium
  • Hydroxyethyl salicylate
  • (1R,2S,5R)-5-METHYL-2-(1-METHYLETHYL)-CYCLOHEXANOL
  • Valid
Authorised in these countries:
  • United Kingdom (Northern Ireland)
Export to PDF

Product identification

Medicine name:
Equiparin 50.000 IU/100 g gel for horses
Active substance and strength:
  • Heparin sodium
    50000.00
    international unit(s)
    /
    100.00
    gram(s)
  • Hydroxyethyl salicylate
    5.00
    gram(s)
    /
    100.00
    gram(s)
  • (1R,2S,5R)-5-METHYL-2-(1-METHYLETHYL)-CYCLOHEXANOL
    0.50
    gram(s)
    /
    100.00
    gram(s)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM02AC99
Authorisation number:
  • VM 24745/4004
Product identification number:
  • 9254b931-4dfc-4f5c-96ae-2d68fcdd0e29
Permanent identification number:
  • 600000060912

Product details

Legal status of supply:
This information is not available for this product.
Pharmaceutical form:
  • Gel
Species grouped by route of administration:
  • Cutaneous use
    • Horse
      • Meat and offal
        0
        day
      • Milk
        no withdrawal period

Availability

Package description:
  • (ID2): 1 unspecified outer container with 6 Bottle (PolyEthylene) with 190 gram(s) (1140 gram(s))
  • (ID1): 1 unspecified outer container with 1 Bottle (PolyEthylene) with 190 gram(s) (190 gram(s))
Manufacturing sites for batch release:
  • Animedica GmbH
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • DE/V/0128/002
Date of authorisation status change:
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Authorisation country:
  • United Kingdom (Northern Ireland)
Responsible authority:
  • VMD
Marketing authorisation holder:
  • Animedica GmbH
Marketing authorisation issued:
Reference member state:
  • Germany
Concerned member states:
  • Austria
  • Hungary
  • Iceland
  • Ireland
  • Poland
  • Spain
  • United Kingdom (Northern Ireland)
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

2401208-spcen-20140930.rtf.pdf (PDF)
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."